Test Category: Immunology
Investigation Name:Anti-Neutrophil Cytoplasmic Antibody (ANCA)
Alias or Abbreviation:ANCA
Intro:
Indication: ANCA Vasculitis specifically: Glomerulonephritis (especially rapidly progressive) Pulmonary haemorrhage (especially pulmonary renal syndrome) Cutaneous vasculitis with systemic features Multiple lung nodules Chronic destructive disease of upper airways Long-standing sinusitis or otitis Subglottic tracheal stenoses Mononeuritis multiplex or other peripheral neuropathies Retro-orbital mass Scleritis Further information: NOTE: MPO and PR3 will be performed as a first-line screen for vasculitis. Other conditions may result in false positive ANCA testing either by immunofluorescence or immunoassay methods. For example, infective endocarditis, tuberculosis, inflammatory bowel disease, hepatitis B & C, malignancy.Requestable Seperately?No
Minimum Sample Volume:1mL
Expected Turnaround Time:Frequency of testing: Twice weekly Target: 7 days
Test Code:ANCF
Sample Type:
Serum Gel Tube (Gold top)Complex Reference Range:Positive Cytoplasmic pattern (C-ANCA)/ Positive Perinuclear pattern (P-ANCA)/ Negative
Collection Conditions / Other Information:1st class post or Transport
Referred to Another Laboratory?No
Storage Requirements:Ambient temperature
NPEX / PDF Reporting Available:Yes
EQA Scheme:Yes
Further information:MPO and PR3 will be performed as a first-line screen for vasculitis. Available for MPO results >3.5 IU/mL or PR3 >2.0 IU/mL on new patients only.
Lead Contact Details:rwh-tr.bcpsimmunologyclinicalqueries@nhs.net
Email Address For Chasing Results:rwh-tr.ImmunologyLab@nhs.net
Methodology:Indirect Immunofluorescence
UKAS Reference Number:Awaiting assessment
Site Sample Tested:Immunology, New Cross Hospital, Wolverhampton
Minimum Request Interval (MRI):180 days (6 months) over 16y only
